{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:14:37Z","timestamp":1768706077141,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 07.821.00"],"award-info":[{"award-number":["TTU 07.821.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 07.821.00"],"award-info":[{"award-number":["TTU 07.821.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 07.801.00"],"award-info":[{"award-number":["TTU 07.801.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU07.821.00"],"award-info":[{"award-number":["TTU07.821.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 07.821.00"],"award-info":[{"award-number":["TTU 07.821.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU07.821.00"],"award-info":[{"award-number":["TTU07.821.00"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human cytomegalovirus (HCMV) reactivation remains a relevant complication after hematopoietic stem cell transplantation (HSCT) despite the great progress made in prophylaxis and treatment. Adaptive Natural Killer (NK) cells undergo a persistent reconfiguration in response to HCMV reactivation however, the exact role of adaptive NK cells in HCMV surveillance is currently unknown. We studied the relationship between HCMV reactivation and adaptive NK cells in 70 patients monitored weekly until day +100 after HSCT. Absolute cell counts of adaptive NK cells increased significantly after resolution of HCMV-reactivation compared to patients without reactivation. Patients with HCMV-reactivation had an early reconstitution of adaptive NK cells (\u201cResponders\u201d) and had mainly a single reactivation (75% Responders vs 48% Non-Responders). Adaptive NK cells eliminated HCMV-infected human foreskin fibroblasts (HFF) in vitro and recruited T cells in an in vitro transwell migration assay. An extensive cytokine\/chemokine panel demonstrated strongly increased secretion of CXCL10\/IP-10, IFN-\u03b1, IL-1\u03b1, IL-1\u03b2, IL-5, IL-7 and CCL4. Thus, adaptive NK cells may control viral spread and T cell expansion and survival during HCMV-reactivation. Taken together, we have demonstrated the potential of adaptive NK cells in the control of HCMV reactivation both by direct cytotoxicity and by recruitment of other immune cells.<\/jats:p>","DOI":"10.1038\/s41409-022-01603-y","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T16:03:06Z","timestamp":1645113786000},"page":"712-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-0211","authenticated-orcid":false,"given":"D\u00e9bora","family":"Bas\u00edlio-Queir\u00f3s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Luther-Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Dammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-3775","authenticated-orcid":false,"given":"Eva M.","family":"Weissinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5500\/wjt.v6.i4.665","volume":"6","author":"N Farhadfar","year":"2016","unstructured":"Farhadfar N, Hogan WJ. Overview of the progress on haploidentical hematopoietic transplantation. World J Transplant. 2016;6:665.","journal-title":"World J Transplant."},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1399-3062.2011.00626.x","volume":"13","author":"S Borchers","year":"2011","unstructured":"Borchers S, Luther S, Lips U, Hahn N, Kontsendorn J, Stadler M, et al. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2011;13:222\u201336.","journal-title":"Transpl Infect Dis."},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"e50248","DOI":"10.1371\/journal.pone.0050248","volume":"7","author":"S Borchers","year":"2012","unstructured":"Borchers S, Bremm M, Lehrnbecher T, Dammann E, Pabst B, W\u00f6lk B, et al. Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation. PLoS ONE. 2012;7:e50248.","journal-title":"PLoS ONE."},{"key":"1603_CR4","unstructured":"Ogonek J, Varanasi PR, Luther S, Schweier P, Dammann E, Woelk B, et al. HLA matching influences the risk of recurrent reactivations and reconstitution of CMV immunity after allogeneic stem cell transplantation. In 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015 March 22-25, 2015:78."},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","volume":"85","author":"A Dolan","year":"2004","unstructured":"Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, et al. Genetic content of wild-type human cytomegalovirus. J Gen Virol. 2004;85:1301\u201312.","journal-title":"J Gen Virol."},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1172\/JCI45449","volume":"121","author":"M Boeckh","year":"2011","unstructured":"Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest. 2011;121:1673\u201380.","journal-title":"J Clin Invest."},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","volume":"200","author":"G Picarda","year":"2018","unstructured":"Picarda G, Benedict CA. Cytomegalovirus: shape-shifting the immune system. J Immunol. 2018;200:3881\u20139.","journal-title":"J Immunol."},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2016.00507","volume":"7","author":"J Ogonek","year":"2016","unstructured":"Ogonek J, Juric MK, Ghimire S, Varanasi PR, Holler E, Greinix H, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2016;7:1\u201315.","journal-title":"Front Immunol."},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","volume":"9","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543\u201358.","journal-title":"Biol Blood Marrow Transplant."},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1182\/blood.V67.3.722.722","volume":"67","author":"T Hercend","year":"1986","unstructured":"Hercend T, Takvorian T, Nowill A, Tantravahi R, Moningeon P, Anderson KC, et al. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood. 1986;67:722\u20138.","journal-title":"Blood."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"108727","DOI":"10.1016\/j.clim.2021.108727","volume":"227","author":"W Zuo","year":"2021","unstructured":"Zuo W, Zhao X. Natural killer cells play an important role in virus infection control: antiviral mechanism, subset expansion and clinical application. Clin Immunol. 2021;227:108727.","journal-title":"Clin Immunol."},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-0988-4","volume":"14","author":"J Drylewicz","year":"2016","unstructured":"Drylewicz J, Schellens IMM, Gaiser R, Nanlohy NM, Quakkelaar ED, Otten H, et al. Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. J Transl Med. 2016;14:1\u20139.","journal-title":"J Transl Med."},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","volume":"104","author":"M Gum\u00e1","year":"2004","unstructured":"Gum\u00e1 M, Angulo A, Vilches C, G\u00f3mez-Lozano N, Malats N, L\u00f3pez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104:3664\u201371.","journal-title":"Blood."},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","volume":"107","author":"M Gum\u00e1","year":"2006","unstructured":"Gum\u00e1 M, Budt M, S\u00e1ez A, Brckalo T, Hengel H, Angulo A, et al. Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107:3624\u201331.","journal-title":"Blood."},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01976","volume":"8","author":"Q Hammer","year":"2018","unstructured":"Hammer Q, R\u00fcckert T, Dunst J, Romagnani C. Adaptive natural killer cells integrate interleukin-18 during target-cell encounter. Front Immunol. 2018;8:1\u20139.","journal-title":"Front Immunol."},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","volume":"119","author":"B Foley","year":"2012","unstructured":"Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C + natural killer cells with potent function. Blood. 2012;119:2665\u201374.","journal-title":"Blood."},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"JC Sun","year":"2009","unstructured":"Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457:557\u201361.","journal-title":"Nature."},{"key":"1603_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","volume":"19","author":"Q Hammer","year":"2018","unstructured":"Hammer Q, R\u00fcckert T, Borst EM, Dunst J, Haubner A, Durek P, et al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells article. Nat Immunol. 2018;19:453\u201363.","journal-title":"Nat Immunol."},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1399-3062.1999.010305.x","volume":"1","author":"M Boeckh","year":"1999","unstructured":"Boeckh M. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transpl Infect Dis. 1999;1:165\u201378.","journal-title":"Transpl Infect Dis."},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","volume":"25","author":"P Ljungman","year":"2011","unstructured":"Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am. 2011;25:151\u201369.","journal-title":"Hematol Oncol Clin North Am."},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1084\/jem.20100762","volume":"208","author":"NK Bj\u00f6rkstr\u00f6m","year":"2011","unstructured":"Bj\u00f6rkstr\u00f6m NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med. 2011;208:13\u201321.","journal-title":"J Exp Med."},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eji.201141826","volume":"42","author":"V B\u00e9ziat","year":"2012","unstructured":"B\u00e9ziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, et al. CMV drives clonal expansion of NKG2C + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol. 2012;42:447\u201357.","journal-title":"Eur J Immunol."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/QAD.0b013e3283328d1f","volume":"24","author":"E Brunetta","year":"2010","unstructured":"Brunetta E, Fogli M, Varchetta S, Bozzo L, Hudspeth KL, Marcenaro E, et al. Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS. 2010;24:27\u201334.","journal-title":"AIDS."},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4049\/jimmunol.1601236","volume":"198","author":"D Redondo-Pach\u00f3n","year":"2017","unstructured":"Redondo-Pach\u00f3n D, Crespo M, Y\u00e9lamos J, Muntasell A, P\u00e9rez-S\u00e1ez MJ, P\u00e9rez-Fern\u00e1ndez S, et al. Adaptive NKG2C + NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients. J Immunol. 2017;198:94\u2013101.","journal-title":"J Immunol."},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/648423","volume":"49","author":"MA Barron","year":"2009","unstructured":"Barron MA, Gao D, Springer KL, Patterson JA, Brunvand MW, McSweeney PA, et al. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)\u2013specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2009;49:1777\u201383.","journal-title":"Clin Infect Dis."},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","volume":"34","author":"J Yu","year":"2013","unstructured":"Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends Immunol. 2013;34:573\u201382.","journal-title":"Trends Immunol."},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mad.2016.06.010","volume":"158","author":"M L\u00f3pez-Botet","year":"2016","unstructured":"L\u00f3pez-Botet M, Muntasell A, Mart\u00ednez-Rodr\u00edguez JE, L\u00f3pez-Monta\u00f1\u00e9s M, Costa-Garc\u00eda M, Pupuleku A. Development of the adaptive NK cell response to human cytomegalovirus in the context of aging. Mechanisms Ageing Dev. 2016;158:23\u20136.","journal-title":"Mechanisms Ageing Dev."},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"e125553","DOI":"10.1172\/jci.insight.125553","volume":"4","author":"F Cichocki","year":"2019","unstructured":"Cichocki F, Taras E, Chiuppesi F, Wagner JE, Blazar BR, Brunstein C, et al. Adaptive NK cell reconstitution is associated with better clinical outcomes. JCI Insight. 2019;4:e125553.","journal-title":"JCI Insight."},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/leu.2015.260","volume":"30","author":"F Cichocki","year":"2016","unstructured":"Cichocki F, Cooley S, Davis Z, DeFor TE, Schlums H, Zhang B, et al. CD56 dim CD57+ NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia. 2016;30:456\u201363.","journal-title":"Leukemia."},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"12396","DOI":"10.1073\/pnas.1635160100","volume":"100","author":"D Yu","year":"2003","unstructured":"Yu D, Silva MC, Shenk T. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci USA. 2003;100:12396\u2013401.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1603_CR31","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1099\/0022-1317-73-9-2395","volume":"73","author":"PD Barnes","year":"1992","unstructured":"Barnes PD, Grundy JE. Down-regulation of the class I HLA heterodimer and \u03b22-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol. 1992;73:2395\u2013403.","journal-title":"J Gen Virol."},{"key":"1603_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0092-8674(00)81054-5","volume":"84","author":"EJHJ Wiertz","year":"1996","unstructured":"Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 1996;84:769\u201379.","journal-title":"Cell."},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud VM, Allan DSJ, O\u2019Callaghan CA, Soderstrom K, D\u2019Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C. Nature. 1998;391:795\u20139.","journal-title":"Nature."},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M, Ishitani A, Navarro F, L\u00f3pez-Botet M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci USA. 1998;95:5199\u2013204.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1603_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/331269a0","volume":"331","author":"S Beck","year":"1988","unstructured":"Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 1988;331:269\u201372.","journal-title":"Nature."},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1074-7613(00)80135-1","volume":"11","author":"TL Chapman","year":"1999","unstructured":"Chapman TL, Heikema AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity. 1999;11:603\u201313.","journal-title":"Immunity."},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"72","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher JP, Bonavita E, Chakravarty P, Blees H, Cabeza-Cabrerizo M, Sammicheli S, et al. NK Cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell. 2018;72:1022\u201337.e14.","journal-title":"Cell."},{"key":"1603_CR38","first-page":"399","volume":"9","author":"MT Lun","year":"1986","unstructured":"Lun MT, Lorino G, Gaeta A, Dessy P, Cipriani P, Filadoro P, et al. In vitro interferon production: induction in human leukocytes after exposure to cytomegalovirus antigens. Microbiologica. 1986;9:399\u2013404.","journal-title":"Microbiologica."},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","volume":"18","author":"S Romagnani","year":"1997","unstructured":"Romagnani S. The Th1\/Th2 paradigm. Immunol Today. 1997;18:263\u20136.","journal-title":"Immunol Today"},{"key":"1603_CR40","first-page":"121","volume":"22","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, et al. CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121\u201330.","journal-title":"Cytokine Growth Factor Rev."},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","volume":"321","author":"A Berger","year":"2000","unstructured":"Berger A. Th1 and Th2 responses: what are they? BMJ. 2000;321:424.","journal-title":"BMJ."},{"key":"1603_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00046","volume":"4","author":"C Neudoerfl","year":"2013","unstructured":"Neudoerfl C, Mueller BJ, Blume C, Daemen K, Stevanovic-Meyer M, Keil J, et al. The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs. Front Immunol. 2013;4:1\u201314.","journal-title":"Front Immunol."},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1128\/JVI.03489-14","volume":"89","author":"Z Wu","year":"2015","unstructured":"Wu Z, Sinzger C, Reichel JJ, Just M, Mertens T. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses. J Virol. 2015;89:2906\u201317.","journal-title":"J Virol."},{"key":"1603_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/hgtb.2019.084","volume":"30","author":"D Bas\u00edlio-Queir\u00f3s","year":"2019","unstructured":"Bas\u00edlio-Queir\u00f3s D, Venturini L, Sampaio KL, Sinzger C, Weissinger EM. Fast and efficient titration of human cytomegalovirus stocks with a self-excisable bacterial artificial chromosomes cassette by flow cytometry. Hum Gene Ther Methods. 2019;30:122\u20136.","journal-title":"Hum Gene Ther Methods"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01603-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T14:04:02Z","timestamp":1652191442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01603-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}